China News Service, Zhuhai, November 30th (Reporter Tang Guijiang) On November 30th, the first China (Macao) International High-quality Consumer Expo and Hengqin World Bay Area Forum officially opened.
The forum is guided by the Macao Special Administrative Region Government, the Guangdong Provincial People's Government, the State-owned Assets Supervision and Administration Commission of the State Council, the Liaison Office of the Central People's Government in the Macao Special Administrative Region, and the China Council for the Promotion of International Trade. Southern Finance All Media Group is the co-organizer of the forum.
As one of the sub-forums of the Hengqin World Bay Area Forum, the "First Hengqin World Bay Area Forum Biomedicine Forum and 2022 China's Big Health Industry" is hosted by the 21st Century Business Herald and the 21st Century New Health Research Institute under the guidance of the Southern Finance and Economics All Media Group. "Summit" was held, and representatives from regulators, industry experts, industry leaders, investment institutions and other parties were invited to focus on the major changes in China's medical and health industry, the Bay Area biomedical industry cluster, Exchanges and discussions on topics such as the survival and development of innovative pharmaceutical companies, and the construction of a "healthy bay area" to explore the future.
At the meeting, the 21st Century New Health Research Institute released the "China Digital Medical Industry Development Trend Report (2022 Edition)" and the excellent case selection results of "Healthy China 21CC Cancer Concern".
The 2022 "Sunshine" case honor list of the 21st century big health industry competitiveness research was also released at the meeting.
The list mainly includes categories such as "benchmarking companies", "enterprises", "people", "public welfare" and "products".
Yu Xiaona, member of the editorial board of Southern Finance and Economics All Media Group and member of the editorial board of 21st Century Business Herald, said in her speech that China's medical and health industry is currently in a golden age of sailing.
In recent years, with the comprehensive and in-depth implementation of the "Healthy China" strategy, my country has gradually established a scientific supervision system for the whole life cycle, guided by clinical needs, and the review and approval process has been continuously accelerated. Under the positive circumstances, biomedicine has become the fastest-growing field in the current medical and health industry.
Gui Yi, director of the Development and Planning Department of the Planning and Information Department of the National Health Commission, said in his speech that Hengqin is one of the major platforms specified in the "Outline of the Development Plan for the Guangdong-Hong Kong-Macao Greater Bay Area". Undertaking major tasks such as the construction of a traditional Chinese medicine science and technology industrial park, it will surely become a display window and a test field to promote the high-quality development of local pharmaceutical products and go global.
Li Shien, deputy director of the Macao Drug Administration, said that Macao has relatively rich medical resources and a wide variety of imported drugs and medical devices.
It is hoped that through system construction, it will provide a legal basis for the development of the small medical device industry in Macau, attract enterprises to settle in Macau and the Shenzhen Cooperation Zone, and grasp the unique advantages of Macau and the development opportunities of the construction of the Shenzhen Cooperation Zone.
Liang Yun, deputy director of the Administrative Licensing Division of the Guangdong Provincial Food and Drug Administration, said that judging from the current implementation of the "Hong Kong-Macau Drug-Device Link", there are still problems in the review and approval process that need to be further optimized and simplified, there is a strong demand for expanding the scope of designated medical institutions, and real-world research and construction There are four outstanding problems in the slow start of work and the need to improve the accessibility of medicine and equipment.
The next step is to focus on these issues to further improve the supervision mechanism and implement the responsibilities of all parties, assist in the determination of the list of the second batch of designated medical institutions, promote the launch of special commercial insurance of "Hong Kong and Macau Medicine and Device Link", promote the work of "Macao New Neighborhood", and update the Guangdong-Hong Kong-Macao Greater Bay in a timely manner List of drugs and medical devices imported from Hong Kong and Macao that are urgently needed in clinical practice in the region, and promote the construction of real-world research in the Guangdong-Hong Kong-Macao Greater Bay Area.
(Finish)